Last10K.com

Aethlon Medical Inc (AEMD) SEC Filing 10-K Annual report for the fiscal year ending Monday, March 31, 2014

Aethlon Medical Inc

CIK: 882291 Ticker: AEMD
Document And Entity Information (USD $)
12 Months Ended
Mar. 31, 2014
Jul. 09, 2014
Sep. 30, 2013
Document And Entity Information      
Entity Registrant Name Aethlon Medical Inc    
Entity Central Index Key 0000882291    
Document Type 10-K    
Document Period End Date Mar. 31, 2014    
Amendment Flag false    
Current Fiscal Year End Date --03-31    
Is Entity a Well-known Seasoned Issuer? No    
Is Entity a Voluntary Filer? No    
Is Entity's Reporting Status Current? Yes    
Entity Filer Category Smaller Reporting Company    
Entity Public Float     $ 36,000,000
Entity Common Stock, Shares Outstanding   253,395,651  
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2014    

View differences made from one year to another to evaluate Aethlon Medical Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Aethlon Medical Inc.

Continue

Assess how Aethlon Medical Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Aethlon Medical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-K Annual Report

Consolidated Balance Sheets
Consolidated Balance Sheets (parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Operations
Consolidated Statements Of Shareholder's Deficit
1. Organization And Summary Of Significant Accounting Policies
1. Organization And Summary Of Significant Accounting Policies (details Narrative)
1. Organization And Summary Of Significant Accounting Policies (details)
1. Organization And Summary Of Significant Accounting Policies (policies)
1. Organization And Summary Of Significant Accounting Policies (tables)
10. Fair Value Measurement (details - Assumptions)
10. Fair Value Measurement (details - Derivative Liabilities)
10. Fair Value Measurements
10. Fair Value Measurements (details - Fair Value Levels)
10. Fair Value Measurements (tables)
11. Darpa Contract And Related Revenue Recognition
11. Darpa Contract And Related Revenue Recognition (details Narrative)
12. Significant Fourth Quarter Adjustments
13. Commitments And Contingencies
13. Commitments And Contingencies (details Narrative)
13. Commitments And Contingencies (details)
13. Commitments And Contingencies (tables)
14. Segments
14. Segments (details)
14. Segments (tables)
15. Subsequent Events (unaudited)
16. Pro Forma Balance Sheet (details)
16. Pro Forma Balance Sheet (unaudited)
16. Pro Forma Balance Sheet (unaudited) (tables)
2. Property And Equipment
2. Property And Equipment (details Narrative)
2. Property And Equipment (details)
2. Property And Equipment (tables)
3. Patents
3. Patents (details Narrative)
3. Patents (details)
3. Patents (tables)
4. Notes Payable
4. Notes Payable (details - Tonaquint Note)
4. Notes Payable (details Narrative)
4. Notes Payable (details)
4. Notes Payable (tables)
5. Convertible Notes Payable
5. Convertible Notes Payable (details - Convertible Note Activity)
5. Convertible Notes Payable (details - Convertible Notes)
5. Convertible Notes Payable (details Narrative)
5. Convertible Notes Payable (tables)
6. Equity Transactions
6. Equity Transactions (details - Option Activity)
6. Equity Transactions (details - Option Assumptions)
6. Equity Transactions (details - Options Exercisable)
6. Equity Transactions (details - Stockbased Compensation)
6. Equity Transactions (details - Warrant Activity)
6. Equity Transactions (details - Warrant Assumptions)
6. Equity Transactions (details - Warrants Exercisable)
6. Equity Transactions (details Narrative)
6. Equity Transactions (tables)
7. Related Party Transactions
8. Other Current Liabilities
8. Other Current Liabilities (details)
8. Other Current Liabilities (tables)
9. Income Taxes
9. Income Taxes (details - Deferred Tax Assets)
9. Income Taxes (details - Provision For Income Taxes)
9. Income Taxes (details Narrative)
9. Income Taxes (tables)
Document And Entity Information

Material Contracts, Statements, Certifications & more

Aethlon Medical Inc provided additional information to their SEC Filing as exhibits

Ticker: AEMD
CIK: 882291
Form Type: 10-K Annual Report
Accession Number: 0001019687-14-002728
Submitted to the SEC: Mon Jul 14 2014 8:00:57 PM EST
Accepted by the SEC: Tue Jul 15 2014
Period: Monday, March 31, 2014
Industry: Laboratory Analytical Instruments

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/aemd/0001019687-14-002728.htm